# Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)

> **NCT02813447** · NA · TERMINATED · sponsor: **Duke University** · enrollment: 13 (actual)

## Conditions studied

- COPD
- Anxiety
- Depression
- Stress
- Interstitial Lung Disease

## Interventions

- **DRUG:** Sertraline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02813447
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2019-02-20
- **Final completion:** 2019-02-20
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** COVID-19 hold
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02813447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02813447, "Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02813447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*